BioCardia Inc (BCDA)
2.74
-0.07
(-2.49%)
USD |
NASDAQ |
Oct 04, 16:00
2.74
0.00 (0.00%)
After-Hours: 20:00
BioCardia Shareholders Equity (Annual): -1.603M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -1.603M |
December 31, 2022 | 4.892M |
December 31, 2021 | 10.38M |
December 31, 2020 | 19.18M |
December 31, 2019 | 2.37M |
December 31, 2018 | 3.792M |
December 31, 2017 | 11.12M |
December 31, 2016 | 20.58M |
December 31, 2015 | 13.87M |
December 31, 2014 | 13.54M |
December 31, 2013 | 13.31M |
December 31, 2012 | 13.29M |
December 31, 2011 | 12.98M |
December 31, 2010 | 3.279M |
December 31, 2009 | 14.74M |
Date | Value |
---|---|
December 31, 2008 | 10.70M |
June 30, 2008 | 2.646M |
June 30, 2007 | 0.0613M |
June 30, 2006 | 0.1169M |
June 30, 2005 | 0.1767M |
June 30, 2004 | 0.9636M |
June 30, 2003 | 1.679M |
June 30, 2002 | 2.093M |
June 30, 2001 | 3.405M |
June 30, 2000 | 6.266M |
June 30, 1999 | 2.20M |
June 30, 1998 | 3.40M |
June 30, 1997 | 4.10M |
June 30, 1996 | -0.0717M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-1.603M
Minimum
2023
19.18M
Maximum
2020
7.042M
Average
4.892M
Median
2022
Shareholders Equity (Annual) Benchmarks
Alnylam Pharmaceuticals Inc | -220.64M |
Theriva Biologics Inc | 39.70M |
Zevra Therapeutics Inc | 61.86M |
PetIQ Inc | 221.21M |
Instil Bio Inc | 225.83M |